시장보고서
상품코드
1938715

수의용 심장병학 시장 보고서(2026년)

Veterinary Cardiology Global Market Report 2026

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

수의 심장병학 시장의 규모는 최근 현저하게 확대하고 있습니다. 2025년 31억 달러에서 2026년에는 33억 8,000만 달러로, CAGR 9.1%로 성장이 전망되고 있습니다. 지난 수년간 성장 요인으로는 반려동물의 선천성 심장병 유병률 증가, 반려동물 의료에 대한 인식 개선, 동물병원 및 진료소 증가, 영상 진단 기술의 발전, 심장질환에 대한 기존 의약품의 채택 등을 꼽을 수 있습니다.

수의 심장병학 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 47억 3,000만 달러에 달하며, CAGR은 8.7%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 수의 심장학 분야에서의 원격의료 도입 확대, 반려동물 보험 적용 범위 확대, AI 기반 진단 툴 개발, 예방적 및 개인화된 심장 치료에 대한 관심 증가, 도시 지역에서의 반려동물 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 원격 심장 진단 및 원격 심전도 모니터링, 최소 침습 심장 수술, 반려동물을 위한 개별 치료 계획, 첨단 심장 영상 진단 기술, 영양 보충제 및 예방적 심장 관리 등이 있습니다.

반려동물 및 가축의 심장질환 발생률 증가는 향후 수의심장학 시장의 성장을 촉진할 것으로 예측됩니다. 반려동물 및 가축의 심장 질환에는 심장의 구조와 기능에 영향을 미치고 혈액순환 장애, 심장 기능 저하, 잠재적인 건강 합병증을 유발하는 질환이 포함됩니다. 심장병 사례 증가는 수명 연장, 비만, 부적절한 식습관, 유전적 소인, 정기적인 수의학적 관리 부족 등의 요인에 의해 촉진되고 있습니다. 환경적 스트레스와 생활환경의 변화도 이들 동물의 심혈관 질환 유병률에 더욱 기여하고 있습니다. 수의심장학은 심장 건강과 삶의 질을 향상시키기 위해 전문적인 진료, 첨단 영상 진단, 최소침습적 수술을 포함한 혁신적인 시술을 통해 심장질환의 진단, 치료, 관리를 돕습니다. 예를 들어 미국 비영리단체인 미국수의사회(AVMA)에 따르면 2024년 3월 현재 북미 개에서 가장 흔한 심장병은 혼합종성 승모판막변성증(MMVD)으로 전체개 심장병의 75%를 차지합니다. 13세 이상의 소형견에서 85%가 승모판막 병변의 징후를 보이지만, 그 임상적 의미는 개인차가 있습니다. MMVD의 경우, 개의 심장 관련 사망률은 40-70%로 추정됩니다. 따라서 반려동물과 가축의 심장질환 발생률 증가가 수의심장학 시장의 성장을 촉진하고 있습니다.

수의심장학 시장의 주요 기업은 심장질환 치료 강화, 수술 결과 개선, 회복 및 삶의 질 향상을 위한 최소침습적 옵션을 제공하기 위해 경카테터 에지 투 에지 승모판막 복원술(TEER)과 같은 기술 혁신을 개발하고 있습니다. TEER는 클램프를 이용해 판막 기능을 개선하고 심장의 부담을 줄여 승모판막 역류를 교정하는 저침습적 시술입니다. 예를 들어 2023년 2월, 영국에 위치한 수의사 의뢰 센터인 윌로우즈 베테리너리 센터(Willows Veterinary Center)는 개에서 가장 흔한 심장 질환인 점액종성 승모판막 질환(MMVD)을 앓고 있는 반려견을 위한 첨단 심장 치료를 시작했습니다. 이 시술은 인간 환자에서 수술적 수복에 대한 효과적인 대안으로 여겨지고 있으며, 반려견의 초기 임상 결과도 유망한 결과를 보여주고 있습니다. 이 시술은 전신마취 하에 가슴의 작은 절개를 통해 이루어집니다. 심장 정점부에 바늘을 삽입하고, 연속 X선 영상과 경식도 초음파의 정밀한 안내에 따라 승모판막에 V자형 클램프를 정확하게 배치하여 판막 역류를 줄입니다.

자주 묻는 질문

  • 수의 심장병학 시장 규모는 어떻게 변화하고 있나요?
  • 수의 심장병학 시장의 성장 요인은 무엇인가요?
  • 수의 심장병학 시장에서의 주요 동향은 무엇인가요?
  • 반려동물의 심장질환 발생률 증가가 시장에 미치는 영향은 무엇인가요?
  • 수의심장학 시장의 주요 기업은 어떤 기술 혁신을 개발하고 있나요?

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA 26.03.04

Veterinary cardiology is a specialized field of veterinary medicine dedicated to diagnosing and managing heart diseases in animals. This branch ranges from routine examinations to advanced treatments, aiming to enhance pets' quality of life by providing targeted diagnosis and treatment for heart conditions, which leads to better health outcomes and longer lifespans.

The primary product types in veterinary cardiology are pharmaceuticals and diagnostics. Pharmaceuticals refer to the medications used to treat heart conditions in animals, such as managing heart failure, arrhythmias, and other cardiovascular issues. Indications for these medications include congestive heart failure, myocardial disease, arrhythmias, and other heart conditions affecting companion animals and production animals. The end users of these products include veterinary hospitals, clinics, and other related facilities.

Tariffs have influenced the veterinary cardiology market by increasing the cost of importing advanced diagnostic equipment and specialized pharmaceuticals, impacting the availability of high-end imaging devices and cardiac drugs. The segments most affected include diagnostics and pharmaceuticals, particularly in regions like Asia-Pacific and North America that rely on imported technologies. While costs have risen, tariffs have also encouraged local manufacturing and innovation in cost-effective cardiac care solutions, providing new opportunities for regional players.

The veterinary cardiology market research report is one of a series of new reports from The Business Research Company that provides veterinary cardiology market statistics, including veterinary cardiology industry global market size, regional shares, competitors with a veterinary cardiology market share, detailed veterinary cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary cardiology industry. This veterinary cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary cardiology market size has grown strongly in recent years. It will grow from $3.1 billion in 2025 to $3.38 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increased prevalence of congenital heart defects in pets, rising awareness about pet healthcare, growing number of veterinary hospitals and clinics, advancements in diagnostic imaging technologies, adoption of conventional pharmaceuticals for cardiac diseases.

The veterinary cardiology market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to rising adoption of telemedicine in veterinary cardiology, growth in pet insurance coverage, development of AI-enabled diagnostic tools, increased focus on preventive and personalized cardiac care, expansion of companion animal population in urban regions. Major trends in the forecast period include telecardiology & remote cardiac monitoring, minimally invasive cardiac procedures, personalized treatment plans for companion animals, advanced cardiac imaging techniques, nutraceuticals & preventive cardiac care.

The rising incidence of heart diseases in pets and livestock is expected to drive the growth of the veterinary cardiology market going forward. Heart diseases in pets and livestock include medical conditions affecting the structure and function of the heart, leading to impaired blood circulation, reduced cardiac efficiency, and potential health complications. The increase in heart disease cases is driven by factors such as longer lifespans, obesity, poor diet, genetic predispositions, and insufficient regular veterinary care. Environmental stressors and changes in living conditions further contribute to the prevalence of cardiovascular conditions in these animals. Veterinary cardiology supports the diagnosis, treatment, and management of heart diseases through specialized care, advanced imaging, and innovative procedures, including minimally invasive surgeries, to improve cardiac health and quality of life. For example, in March 2024, according to the American Veterinary Medical Association, a US-based not-for-profit organization, myxomatous mitral valve degeneration (MMVD) is the most common heart disease in dogs in North America, accounting for 75% of all canine cardiac conditions. Among small dogs aged 13 years, 85% show signs of a mitral valve lesion, although its clinical significance may vary. In cases of MMVD, cardiac-related deaths in dogs are estimated between 40% and 70%. Therefore, the rising incidence of heart diseases in pets and livestock is driving the growth of the veterinary cardiology market.

Leading players in the veterinary cardiology market are developing technological innovations, such as transcatheter edge-to-edge mitral valve repair (TEER), to enhance the treatment of heart diseases, improve surgical outcomes, and provide minimally invasive alternatives for better recovery and quality of life. TEER is a less invasive procedure designed to correct mitral valve leakage by using a clamp to improve valve function and reduce cardiac strain. For example, in February 2023, Willows Veterinary Centre, a UK-based veterinary referral center, launched an advanced heart treatment for dogs with myxomatous mitral valve disease (MMVD), the most common heart condition in dogs. This procedure is considered a viable alternative to surgical repair in human patients, with early clinical results in dogs showing promising outcomes. The procedure is performed under general anesthesia through a minor chest incision. A needle is inserted at the heart's apex, with precise guidance from continuous X-rays and transesophageal ultrasound, allowing accurate placement of a V-clamp across the mitral valve to reduce leakage.

In October 2023, EQT AB, a Sweden-based investment organization, acquired VetPartners for $940 million. This acquisition supports EQT's strategy to expand its investment portfolio within the animal health sector, aiming to elevate veterinary service standards and address increasing demand for animal healthcare. VetPartners is a UK-based veterinary group providing comprehensive cardiology care and services for animals.

Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Sante Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet

North America was the largest region in the veterinary cardiology market in 2025. The regions covered in the veterinary cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary cardiology market consists of revenues earned by entities by providing services such as educational services, emergency care, telemedicine services, follow-up care, and consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. veterinary cardiology market also includes sales of monitoring devices, treatment products, supportive products, and surgical products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Cardiology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary cardiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary cardiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary cardiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Pharmaceuticals; Diagnostics
  • 2) By Indication: Congestive Heart Failure; Myocardial (Heart Muscle) Disease; Arrhythmias; Other Indications
  • 3) By Animal Type: Companion Animals; Production Animals
  • 4) By End-User: Veterinary Hospitals; Clinics; Other End Users
  • Subsegments:
  • 1) By Pharmaceuticals: Antihypertensives; Diuretics; Antiarrhythmic Drugs; Beta Blockers; ACE Inhibitors; Calcium Channel Blockers; Positive Inotropes; Nutraceuticals For Cardiac Health
  • 2) By Diagnostics: Electrocardiograms (ECG); Echocardiography Devices; Holter Monitors; Blood Pressure Monitors; Cardiac Biomarker Tests; Thoracic Radiography; Ultrasound Devices; Telemedicine Solutions for Cardiac Monitoring
  • Companies Mentioned: Merck & Co. Inc.; Medtronic plc; Siemens Healthineers AG; Zoetis Inc.; Boehringer Ingelheim Animal Health; Royal Canin; IDEXX Laboratories Inc.; Ceva Sante Animale S.A.; Fujifilm Healthcare Solutions; Dechra Pharmaceuticals PLC; Vetoquinol S.A.; ESAOTE S.p.A.; SonoScape Medical Corp.; Jurox Pty Limited; Eickemeyer Veterinary Equipment GmbH; VetriScience Laboratories Inc.; Bionet America Inc.; Scil Animal Care Company; Woodley Equipment Company Ltd.; Universal Imaging Corporation; VetBlue Inc.; TeleVet
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Veterinary Cardiology Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Veterinary Cardiology Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Veterinary Cardiology Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Veterinary Cardiology Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Biotechnology, Genomics & Precision Medicine
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Telecardiology & Remote Cardiac Monitoring
    • 4.2.2 Minimally Invasive Cardiac Procedures
    • 4.2.3 Personalized Treatment Plans For Companion Animals
    • 4.2.4 Advanced Cardiac Imaging Techniques
    • 4.2.5 Nutraceuticals & Preventive Cardiac Care

5. Veterinary Cardiology Market Analysis Of End Use Industries

  • 5.1 Veterinary Hospitals
  • 5.2 Veterinary Clinics
  • 5.3 Specialty Cardiac Centers
  • 5.4 Research Institutes
  • 5.5 Academic & Training Institutions

6. Veterinary Cardiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Cardiology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Veterinary Cardiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Veterinary Cardiology Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Veterinary Cardiology Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Veterinary Cardiology Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Cardiology Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Cardiology Market Segmentation

  • 9.1. Global Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceuticals, Diagnostics
  • 9.2. Global Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Other Indications
  • 9.3. Global Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Companion Animals, Production Animals
  • 9.4. Global Veterinary Cardiology Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Veterinary Hospitals, Clinics, Other End Users
  • 9.5. Global Veterinary Cardiology Market, Sub-Segmentation Of Pharmaceuticals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antihypertensives, Diuretics, Antiarrhythmic Drugs, Beta Blockers, ACE Inhibitors, Calcium Channel Blockers, Positive Inotropes, Nutraceuticals For Cardiac Health
  • 9.6. Global Veterinary Cardiology Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Electrocardiograms (ECG), Echocardiography Devices, Holter Monitors, Blood Pressure Monitors, Cardiac Biomarker Tests, Thoracic Radiography, Ultrasound Devices, Telemedicine Solutions for Cardiac Monitoring

10. Veterinary Cardiology Market Regional And Country Analysis

  • 10.1. Global Veterinary Cardiology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Veterinary Cardiology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Cardiology Market

  • 11.1. Asia-Pacific Veterinary Cardiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Cardiology Market

  • 12.1. China Veterinary Cardiology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Cardiology Market

  • 13.1. India Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Cardiology Market

  • 14.1. Japan Veterinary Cardiology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Cardiology Market

  • 15.1. Australia Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Cardiology Market

  • 16.1. Indonesia Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Cardiology Market

  • 17.1. South Korea Veterinary Cardiology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Cardiology Market

  • 18.1. Taiwan Veterinary Cardiology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Cardiology Market

  • 19.1. South East Asia Veterinary Cardiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Cardiology Market

  • 20.1. Western Europe Veterinary Cardiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Cardiology Market

  • 21.1. UK Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Cardiology Market

  • 22.1. Germany Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Cardiology Market

  • 23.1. France Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Cardiology Market

  • 24.1. Italy Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Cardiology Market

  • 25.1. Spain Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Cardiology Market

  • 26.1. Eastern Europe Veterinary Cardiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Cardiology Market

  • 27.1. Russia Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Cardiology Market

  • 28.1. North America Veterinary Cardiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Cardiology Market

  • 29.1. USA Veterinary Cardiology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Cardiology Market

  • 30.1. Canada Veterinary Cardiology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Cardiology Market

  • 31.1. South America Veterinary Cardiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Cardiology Market

  • 32.1. Brazil Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Cardiology Market

  • 33.1. Middle East Veterinary Cardiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Cardiology Market

  • 34.1. Africa Veterinary Cardiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Veterinary Cardiology Market, Segmentation By Product, Segmentation By Indication, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Cardiology Market Regulatory and Investment Landscape

36. Veterinary Cardiology Market Competitive Landscape And Company Profiles

  • 36.1. Veterinary Cardiology Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Veterinary Cardiology Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Veterinary Cardiology Market Company Profiles
    • 36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Cardiology Market Other Major And Innovative Companies

  • Royal Canin, IDEXX Laboratories Inc., Ceva Sante Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation

38. Global Veterinary Cardiology Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Cardiology Market

40. Veterinary Cardiology Market High Potential Countries, Segments and Strategies

  • 40.1 Veterinary Cardiology Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Veterinary Cardiology Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Veterinary Cardiology Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제